The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8754075, 28 ID: ALA3680880
Chembl Id: CHEMBL3680880
PubChem CID: 66558856
Max Phase: Preclinical
Molecular Formula: C15H14ClF2N5O2
Molecular Weight: 369.76
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C[C@]1(c2cc(NC(=O)c3[nH]ncc3Cl)ccc2F)N=C(N)OC[C@@H]1F
Standard InChI: InChI=1S/C15H14ClF2N5O2/c1-15(11(18)6-25-14(19)22-15)8-4-7(2-3-10(8)17)21-13(24)12-9(16)5-20-23-12/h2-5,11H,6H2,1H3,(H2,19,22)(H,20,23)(H,21,24)/t11-,15+/m0/s1
Standard InChI Key: DSOVCCKHSOQORN-XHDPSFHLSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 369.76Molecular Weight (Monoisotopic): 369.0804AlogP: 2.35#Rotatable Bonds: 3Polar Surface Area: 105.39Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.16CX Basic pKa: 6.20CX LogP: 1.97CX LogD: 1.97Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.77Np Likeness Score: -1.24
References 1. (2014) 1,3-oxazines as BACE1 and/or BACE2 inhibitors,